Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety
1
x
$
30.00
View Cart
Checkout
Home
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
“Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety” has been added to your cart.
View cart
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-40-3-sheehan
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 3 Articles
Tags:
aminobutyric-acid-gaba
,
anxiety
,
b-ashok-raj
,
david-v-sheehan
,
juris-janavs
,
kathy-harnett-sheehan
,
mba
,
md
,
panic-disorder
,
phd
,
selective-gaba-reuptake-inhibitor
,
tiagabine
Description
Description
David V. Sheehan, MD
Link
NEGATIVE AND FAILED CLINICAL TRIAL REPORTS
An Open-Label Study of Tiagabine in
Panic Disorder
David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, B. Ashok Raj, MD, and Juris Janavs, MD
Related products
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Naomi M. Simon, MD: Bupropion Sustained Release for Panic Disorder
$
30.00
Add to cart
Details
Paul A. Cannistraro, MD: Neural Circuitry of Anxiety: Evidence from Structural and Functional Neuroimaging Studies
$
30.00
Add to cart
Details
Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects
$
0.00
Add to cart
Details
Page load link
Go to Top
